Neurology News

CHARLOTTE, N.C. – Sharing a bed with a spouse or partner generally led to better sleep and lower levels of depression and anxiety, according to Michael Grandner, PhD, MTR, CBSM, FAASM, at the SLEEP meeting.

In this edition, Break Through Cancer awards $50M to fund a ‘radical collaboration’ in cancer research; the FDA grants a breakthrough device designation for an MS plasma test; App-based mental exercises may improve cognitive impairment; and more.

The Kessler Foundation received multiple grants from the New Jersey Health Foundation for research projects that aim to improve cognition and mobility in patients with neurological disabilities, the foundation announced in a press release.

Women with a history of endometriosis had elevated risk for stroke compared with women without a history of endometriosis, with a greater risk for women who underwent hysterectomy or oophorectomy, researchers reported.

Researchers found that topical CBD products purchased online and in retail stores were often inaccurately labeled, and many contained THC, highlighting the need for improved regulatory oversight, according to a report in JAMA Network Open.

The FDA has approved Neuronetics’ NeuroStar Advanced Therapy for Mental Health, a transcranial magnetic stimulation system for treatment of anxiety symptoms in adults with major depressive disorder, the company announced in a press release.

The U.S. Supreme Court’s recent decision to overturn Roe v. Wade will compromise standard neurological care for approximately 40 million women in as many as 28 states, educators wrote in JAMA Neurology.

The COVID-19 pandemic negatively impacted caregivers and non-caregivers alike, with evidence of increased alcohol consumption and depressive symptoms along with significant sleep disturbances, according to a study published in Alcohol.

The FDA has granted tentative approval to Lumryz, a once-at-bedtime oral treatment for excessive daytime sleepiness or cataplexy in adults with narcolepsy, Avadel Pharmaceuticals announced in a press release.

Adherence to a Mediterranean diet was associated with better cognitive performance and decreased learning and memory decline after 7 years among middle-aged and older Hispanic or Latino adults, per a study published in JAMA Network Open.